LERU Briefing Paper: How to improve the development of Advanced Therapy Medicinal Products at universities

被引：0
|
作者：
Meij, P. [1 ]
Scott, M. [2 ,3 ]
Canals, J. M. [4 ,6 ,7 ,8 ]
Lowery, M. [5 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands
[2] Univ Cambridge, Sch Clin Med, Cambridge, England
[3] Advent Bioserv, Cambridge, England
[4] Univ Barcelona, Lab Stem Cells & Regenerat Med, Barcelona, Spain
[5] Univ Dublin, Trinity Coll Dublin, Dublin, Ireland
[6] Univ Barcelona, Creatio Prod & Validat Ctr Adv therapies, Barcelona, Spain
[7] August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
[8] Networked Biomed Res Ctr Neurodegenerat Disorders, Madrid, Spain
来源：
CYTOTHERAPY | 2020年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
345
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [21] Revised guideline for advanced therapy medicinal products
    Reactions Weekly, 2018, 1689 (1) : 4 - 4
  • [22] Clinical trials with advanced therapy medicinal products
    Schuessler-Lenz, M.
    Schneider, C. K.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2010, 53 (01) : 68 - 74
  • [23] Development of advanced therapy medicinal products: need of specialized regulatory services support
    del Campo, A. B.
    Paneda, A.
    Jimenez, I.
    Berlanga, A.
    Mork, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A2 - A2
  • [24] The expanding role of blood and tissue establishments in the development of advanced therapy medicinal products
    Horan, Aisling
    Warreth, Shada
    Hervig, Tor
    Waters, Allison
    CYTOTHERAPY, 2024, 26 (05) : 524 - 530
  • [25] Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
    Boran, Tomas
    Menezes-Ferreira, Margarida
    Reischl, Ilona
    Celis, Patrick
    Ferry, Nicolas
    Gaensbacher, Bernd
    Krafft, Hartmut
    di Paola, Michele Lipucci
    Sladowski, Dariusz
    Salmikangas, Paula
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2017, 28 (03) : 126 - 135
  • [26] Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive
    Maciulaitis, Romaldas
    D'Apote, Lucia
    Buchanan, Andrew
    Pioppo, Laura
    Schneider, Christian K.
    MOLECULAR THERAPY, 2012, 20 (03) : 479 - 482
  • [27] European regulatory experience with advanced therapy medicinal products
    Barkholt, Lisbeth
    Voltz-Girolt, Caroline
    Raine, June
    Salmonson, Tomas
    Schuessler-Lenz, Martina
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (01) : 8 - +
  • [28] THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S428 - S428
  • [29] CURRENT DEVELOPMENTS IN THE REGULATION OF ADVANCED THERAPY MEDICINAL PRODUCTS
    Ruiz, S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 15 - 16
  • [30] Access Challenges of Advanced Therapy Medicinal Products in Europe
    Szulc, E.
    Tschumi, B.
    Pennese, N.
    Lecureuil, C.
    Robbins, S.
    VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
12345